MNKD

#2576
Mannkind Corporation
2.7400 USD
+3.79%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.7400
2.7400
Intervallo Annuale
2.2300
6.5100
Variazione giornaliera
+3.79%
Variazione Mensile
-1.08%
Variazione di 6 mesi
-48.30%
Variazione Annuale
-48.30%
Chiusura Precedente
2.6400
Apertura
2.7400
Bid
Ask
Minimo
2.7400
High
2.7400
Volume
81
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 844.1952 M
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
283.5
Rapporto prezzo/fatturato
5.25

MannKind Corporation

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

Notizie